Comment on

• Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.

  Modrego PJ, Fayed N, Pina MA. Modrego PJ, et al. Am J Psychiatry. 2005 Apr;162(4):667-75. doi: 10.1176/appi.ajp.162.4.667. Am J Psychiatry. 2005. PMID: 15800137
• Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

  Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E. Hashimoto M, et al. Am J Psychiatry. 2005 Apr;162(4):676-82. doi: 10.1176/appi.ajp.162.4.676. Am J Psychiatry. 2005. PMID: 15800138 Clinical Trial.
• Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.

  Yaffe K, Krueger K, Cummings SR, Blackwell T, Henderson VW, Sarkar S, Ensrud K, Grady D. Yaffe K, et al. Am J Psychiatry. 2005 Apr;162(4):683-90. doi: 10.1176/appi.ajp.162.4.683. Am J Psychiatry. 2005. PMID: 15800139 Clinical Trial.